Prescription drug · ANDA
Piroxicam NDC 42291-954
Piroxicam 20 mg/1 · Capsule · Oral · AvKARE
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42291-954-01 | 42291095401 | 100 CAPSULE in 1 BOTTLE (42291-954-01)Marketed from Aug 1, 2024 | |
| 42291-954-50 | 42291095450 | 500 CAPSULE in 1 BOTTLE (42291-954-50)Marketed from Aug 1, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Piroxicam
- Generic name (nonproprietary)
- piroxicam
- Active ingredients
- Piroxicam — 20 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- AvKARE
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 210347
- Marketing start
- Listing expires
- Other FDA classes
- Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
- Identifiers
- Product ID 42291-954_48c0e9da-a0ba-1b18-e063-6294a90a5957SPL ID 48c0e9da-a0ba-1b18-e063-6294a90a5957SPL set ID 1ea6042e-0090-df18-e063-6394a90a0a0aRxCUI 198107, 198108UNII 13T4O6VMAMUPC 0342291954014, 0342291953017
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442291095401followed by a unit qualifier and the quantityPackage 42291-0954-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Piroxicam Capsules are a nonsteroidal anti-inflammatory drug indicated for Relief of the signs and symptoms of osteoarthritis (OA) (1) Relief of the signs and symptoms of rheumatoid arthritis (RA) (1) Piroxicam Capsules are indicated: For relief of the signs and symptoms of osteoarthritis. For relief of the signs and symptoms of rheumatoid arthritis.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 210347
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Piroxicam | Piroxicam 20 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-2067 |
| Piroxicam | Piroxicam 10 mg/1 | CapsuleOral | AvKARE | 42291-953 |
| Piroxicam | Piroxicam 10 mg/1 | CapsuleOral | Strides Pharma Science Limited | 64380-842 |
| Piroxicam | Piroxicam 20 mg/1 | CapsuleOral | Strides Pharma Science Limited | 64380-843 |
| Piroxicam | Piroxicam 10 mg/1 | CapsuleOral | PD-Rx Pharmaceuticals, Inc. | 72789-210 |
| Piroxicam | Piroxicam 20 mg/1 | CapsuleOral | PD-Rx Pharmaceuticals, Inc. | 72789-211 |
| Piroxicam | Piroxicam 20 mg/1 | CapsuleOral | Direct_Rx | 72189-350 |